PRESS RELEASE Date: 18 February 2004

Subject: FLUOROtechnics and the Australian Proteome Analysis Facility receive an Australian Technology Demonstration Grant from the New South Wales Government.

FLUOROtechnics is pleased to announce that through the Australian Technology Demonstration Program the Australian Proteome Analysis Facility (APAF) has successfully completed a trial FLUOROtechnics first product ‘Deep PurpleTM Total Protein Stain.’

APAF’s Major Findings were that Deep Purple Total Protein Stain:

1. Is more sensitive than SyproTM Ruby for 1D gels.
2. Detects more protein spots by image analysis than Sypro Ruby.
3. Detects up to 84% more cytoskeletal proteins than Sypro Ruby.
4. Is particularly good at detecting alkaline and small (<25kd) proteins.
5. Produced a significantly lower background staining.
6. Exhibited a superior signal to noise ratio than Sypro Ruby.
7. Is fully compatible with MS and MS/MS.
APAF is routinely using Deep Purple and other novel proteomics technologies in its recently launched cancer research program,

The Technology Demonstration Grant is a key component of the New South Wales Government Australian Technology Showcase Initiative.

Deep Purple is exclusively licensed to Amersham Biosciences by FLUOROtechnics. Further details from http://www.amershambiosciences.com or please refer to Amersham Biosciences press release October 2003. (113kb PDF)

Contact: Professor Duncan Veal, CEO
Fluorotechnics Pty Limited
Email: dveal@fluorotechnics.com

Contact: Professor Mark Baker, CEO
Australian Proteome Analysis Facility
Email: mbaker@proteome.org.au

Ref: press release – ATS Tech Demo Grant – Feb 2004